(Q24201094)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24442580%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Graeme Tosh

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24442580%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Jun Xia

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24442580%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Margueritte M White

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24442580%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

1 June 2020

publication date

17 January 2014

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24442580%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24442580%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

CD008298

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24442580%20AND%20SRC:MED&resulttype=core&format=json

Comparison of metabolic and prolactin variables from a six-month randomised trial of olanzapine and quetiapine in schizophrenia

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Glutathione precursor N-acetyl-cysteine modulates EEG synchronization in schizophrenia patients: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Sleep propensity at daytime as assessed by Multiple Sleep Latency Tests (MSLT) in patients with schizophrenia increases with clozapine and olanzapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Cholesterol and cognition in schizophrenia: a double-blind study of patients randomized to clozapine, olanzapine and haloperidol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Hematological clozapine monitoring with a point-of-care device: a randomized cross-over trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Metabolic parameters in the short- and long-term treatment of schizophrenia with sertindole or risperidone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

An oral health intervention for people with serious mental illness (Three Shires Early Intervention Dental Trial): study protocol for a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Clozapine versus other atypical antipsychotics for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Statistics notes. Trials randomised in clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Healthy living interventions and schizophrenia: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Twenty-five year mortality of a community cohort with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Evidence-based mental health policy: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

The unit of analysis error in studies about physicians' patient care behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

The association of medical comorbidity in schizophrenia with poor physical and mental health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Issues in the meta-analysis of cluster randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Clozapine versus typical neuroleptic medication for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Imputing missing standard deviations in meta-analyses can provide accurate results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Smoking cessation advice for people with serious mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Oral health advice for people with serious mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Sertindole versus other atypical antipsychotics for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Olanzapine versus other atypical antipsychotics for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Clinical implications of Brief Psychiatric Rating Scale scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

What does the PANSS mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Is the superior efficacy of new generation antipsychotics an artifact of LOCF?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Treatment programmes for people with both severe mental illness and substance misuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Physical health monitoring of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Case management: a dubious practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Case management for people with severe mental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Mortality in a cohort of patients with schizophrenia: a record linkage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Serious mental illness and physical health problems: a discussion paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Definition and prevalence of severe and persistent mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

An empirical literature review of definitions of severe and persistent mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Evidence-based practice as mental health policy: three controversies and a caveat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

General physical health advice for people with serious mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Influence of antipsychotics on mortality in schizophrenia: systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

The development of the serious mental illness physical Health Improvement Profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

HIV prevention advice for people with serious mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

Interpreting Results and Drawing Conclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

The effect of self- vs. external-monitoring and locus of control upon the pacing and general adjustment of psychiatric inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008298.PUB3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/14651858.CD008298.PUB3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24442580%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference